MarketCap
Facebook
X
Telegram
Bio-Rad Laboratories Market Cap | BIO
As of September 14, 2026 Bio-Rad Laboratories has a market cap of $ 10.1 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Bio-Rad Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.9 B | 7.81 B | 9.86 B | 14.3 B | 17.9 B | 17.1 B | 11 B | 7.31 B | 7.69 B | 5.49 B | 3.72 B | 3.31 B | 3.68 B | 3.26 B | 2.89 B | 2.52 B | 2.07 B | 2.39 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.9 B | 2.07 B | 7.12 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
12.9 B | $ 153.68 | 1.9 % | $ 11.1 B |  USA |
 |
Apyx Medical Corporation
APYX
|
142 M | $ 2.94 | 1.38 % | $ 121 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 10.79 | 1.98 % | $ 1.62 B | USA |
 |
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 43.57 | 3.33 % | $ 2.01 B | USA |
 |
Bruker Corporation
BRKR
|
5.58 B | $ 52.5 | 0.19 % | $ 7.97 B | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 45.06 | 4.84 % | $ 66.7 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
591 M | $ 8.3 | 3.43 % | $ 605 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 13.56 | 0.18 % | $ 384 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 46.62 | 0.69 % | $ 1.45 B | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 6.07 | 0.63 % | $ 378 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 5.9 | 2.46 % | $ 797 M | USA |
 |
Electromed
ELMD
|
325 M | $ 26.56 | 0.4 % | $ 220 M | USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 71.77 | 1.17 % | $ 2.13 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 85.93 | 1.85 % | $ 50.3 B | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 75.39 | 1.62 % | $ 10.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
4.03 B | $ 2.28 | 2.7 % | $ 50.3 M | USA |
 |
Inogen
INGN
|
160 M | $ 5.28 | 0.09 % | $ 140 M | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 14.88 | 0.2 % | $ 962 M | Israel |
 |
Abbott Laboratories
ABT
|
196 B | $ 102.99 | 1.02 % | $ 179 B | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.65 | 0.74 % | $ 11 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 82.87 | 0.79 % | $ 1.05 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 126.19 | 0.15 % | $ 4.38 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 22.32 | 1.16 % | $ 524 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 79.62 | 1.84 % | $ 4.34 B |  Britain |
|
LENSAR
LNSR
|
71.3 M | $ 7.87 | 3.55 % | $ 94.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.98 | 6.76 % | $ 80.6 M | USA |
 |
Medtronic PLC
MDT
|
102 B | $ 93.77 | 3.08 % | $ 120 B | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 4.58 | 0.11 % | $ 677 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 1.29 | 1.17 % | $ 54 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
339 M | $ 0.72 | 2.03 % | $ 46.6 M | Israel |
 |
InspireMD
NSPR
|
115 M | $ 0.81 | 2.13 % | $ 52.1 M | Israel |
 |
Orthofix Medical
OFIX
|
491 M | $ 9.01 | 0.86 % | $ 357 M |  Curacao |
 |
Outset Medical
OM
|
52.5 K | $ 3.18 | 0.31 % | $ 48.4 K | USA |
 |
PAVmed
PAVM
|
5.81 M | $ 4.21 | 0.72 % | $ 2.82 M | USA |
 |
Penumbra
PEN
|
13.2 B | $ 320.04 | 0.73 % | $ 12.5 B | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 137.17 | 3.95 % | $ 9.65 B | USA |
 |
Profound Medical Corp.
PROF
|
166 M | $ 5.86 | 0.17 % | $ 177 M |  Canada |
 |
Quanterix Corporation
QTRX
|
269 M | $ 2.44 | 2.15 % | $ 104 M | USA |
 |
AVITA Medical
RCEL
|
104 M | $ 10.34 | 4.66 % | $ 288 M |  Australia |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 1.74 | 2.2 % | $ 4.83 M | USA |
 |
Smith & Nephew plc
SNN
|
27.4 B | $ 28.44 | 3.42 % | $ 24.7 B | Britain |
 |
Sensus Healthcare
SRTS
|
72.3 M | $ 3.13 | 0.16 % | $ 51.1 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 283.31 | 2.81 % | $ 108 B | USA |
 |
TELA Bio
TELA
|
32.4 M | $ 1.02 | 5.15 % | $ 47.9 M | USA |
 |
TransMedics Group
TMDX
|
4.69 B | $ 88.05 | 7.14 % | $ 2.99 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 16.97 | 0.06 % | $ 1.15 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Viemed Healthcare
VMD
|
352 M | $ 8.81 | 0.17 % | $ 343 M | USA |